Target intelligence / Profile preview

Hemoglobin subunit theta 1 (HBQ1)

Target
HBQ1
Molecular classification
Oxygen transporter protein, Alpha-globin family (hemoglobin gene cluster), Other
01

Overview

Hemoglobin subunit theta 1 is a member of the human alpha-globin gene cluster, encoding a globin protein that is mainly expressed in fetal erythroid tissues in very early embryonic development. Unlike the major adult hemoglobins, theta-globin is predominately absent from adult erythroid tissues. Its primary roles include oxygen transport as part of fetal hemoglobin, and emerging evidence points to a regulatory or antioxidative function in non-erythroid cells, particularly in cancer where its overexpression is linked to increased cell proliferation and poor clinical outcome in lung adenocarcinoma. The gene is located on chromosome 16 within the alpha-globin cluster, and its sequence shares homology but not identity with other alpha-globin subunits, suggesting a distinct functional role in development and disease.

Other names
Hemoglobin theta-1 chainTheta-1-globinHBQhemoglobin, theta 1hemoglobin subunit θ 1haemoglobin subunit theta 1haemoglobin subunit θ 1
02

Mechanism of action

For drugs that would theoretically target this molecule, mechanisms might include inhibition of oncogenic functions (cell proliferation), modulation of oxygen transport or antioxidant capacity, but no such drugs are documented in current sources.

03

Biological functions

Oxygen bindingIron ion bindingOxygen transporter activityRegulation during early embryonic erythropoiesisAntioxidant function (reduces reactive oxygen species in some contexts, especially cancer cells)
04

Disease associations

Cancer (notably promotes proliferation in lung adenocarcinoma)Alpha-thalassemiaHemoglobin H disease
05

Safety considerations

Potential safety concerns relate to the impact on oxygen transport and redox balance if targeted therapeutically in cancer—off-target effects and impact on erythropoiesis could be a challenge
06

Interacting drugs

No specific drugs are currently listed as interacting directly with HBQ1 in existing references. Hemoglobin-modulating agents target the hemoglobin protein in general but not the theta-1 chain selectively.
07

Biomarkers

High HBQ1 expression may serve as a diagnostic or prognostic biomarker in lung adenocarcinoma, correlating with poor survival and disease progression

Beyond the preview

Go deeper on Hemoglobin subunit theta 1 (HBQ1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemoglobin subunit theta 1 (HBQ1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call